PIXCLARA
TELIX · FLORETYROSINE F-18
Open FDA's page for this record- Application number
- NDA218592
- Sponsor name
- TELIX
- Submissions
- Submission type
- ORIG
- Submission number
- 1
- Submission status
- AP
- Submission status date
- 20260911
- Review priority
- PRIORITY
- Submission class code
- TYPE 1
- Submission class code description
- Type 1 - New Molecular Entity
- Submission property type
- Code
- Orphan
- Application docs
- ID
- 87194
- Url
- https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/218592Orig1s000lbl.pdf
- Date
- 20260915
- Type
- Label
- ID
- 87195
- Url
- https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2026/218592Orig1s000ltr.pdf
- Date
- 20260915
- Type
- Letter
- ID
- 87408
- Url
- https://www.accessdata.fda.gov/drugsatfda_docs/nda/2026/218592Orig1s000TOC.html
- Date
- 20261013
- Type
- Review
- Products
- Product number
- 001
- Reference drug
- Yes
- Brand name
- PIXCLARA
- Reference standard
- Yes
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Marketing status
- Prescription
- Active ingredients
- Name
- FLORETYROSINE F-18
- Strength
- 5-300mCi/ML
- Harmonized identifiers (openFDA)
- Application number
- NDA218592
- Brand name
- PIXCLARA
- Generic name
- FLORETYROSINE F18
- Manufacturer name
- Telix Pharmaceuticals (US) Inc.
- Product NDC
- 74725-338
- Product type
- HUMAN PRESCRIPTION DRUG
- Route
- INTRAVENOUS
- Substance name
- FLORETYROSINE F-18
- SPL ID
- 090d1c29-29d4-4fc0-98d0-0442841e1a7b
- SPL set ID
- dc78b128-3768-4448-b019-61574db05714
- Package NDC
- 74725-338-30
- UNII
- 1326R5J1IA
